Lower risk of hypoglycaemia and greater odds for weight loss with initiation of insulin detemir compared with insulin glargine in Turkish patients with type 2 diabetes mellitus: local results of a multinational observational study

被引：0

作者：

Taner Damci

Rifat Emral

Anne Louise Svendsen

Tanzer Balkir

Jiten Vora

机构：

[1] Cerrahpasa Medical School,Department of Endocrinology, Diabetes and Metabolism

[2] Istanbul University,Department of Endocrinology and Metabolic Diseases, Faculty of Medicine

[3] Ankara University,Department of Clinical, Medical, & Regulatory Affairs

[4] Ibn-i Sina Hospital,Department of Diabetes and Endocrinology

[5] Department of Biostatistics & Epidemiology,undefined

[6] Novo Nordisk Saglik Urunleri Tic. Ltd. Sti.,undefined

[7] Royal Liverpool University Hospital,undefined

[8] the SOLVE™ study group,undefined

来源：

BMC Endocrine Disorders | / 14卷

关键词：

Insulin detemir; Insulin glargine; Basal insulin; Type 2 diabetes; Weight loss; Hypoglycaemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Comparing insulin glargine (GLAR) with insulin detemir (DET) - effects on HbA1c on weight change and insulin dose in patients with type 2 diabetes
Dailey, G.
Admane, K.
Mercier, F.
Owens, D.
DIABETOLOGIA, 2009, 52 : S381 - S381
[42] LOWER TREATMENT COSTS WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN TYPE-2 DIABETES PATIENTS ON BASAL-BOLUS THERAPY UNDER REAL WORLD CONDITIONS IN GERMANY
Bierwirth, R.
Kohlmann, T.
Dippel, F. W.
Landgraf, W.
Holle, R.
VALUE IN HEALTH, 2009, 12 (07) : A408 - A408
[43] Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy:: Comparison of insulin glargine with NPH insulin as basal insulin supplement
Ploeckinger, Ursula
Topuz, Mendaha
Riese, Brigitte
Reuter, Thomas
DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 290 - 295
[44] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
Haak, T
Tiengo, A
Draeger, E
Suntum, M
Waldhäusl, W
DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
[45] Exenatide added to insulin glargine-treated patients with type 2 diabetes provided excellent fasting and postprandial control with weight loss and no increased risk of hypoglycaemia
Bergenstal, R. M.
Buse, J. B.
Glass, L. C.
Heilmann, C. R.
Lewis, M. S.
Kwan, A. Y. M.
Hoogwerf, B. J.
Rosenstock, J.
DIABETOLOGIA, 2010, 53 : S37 - S37
[46] Similar efficacy and safety with LY2963016 insulin glargine compared with insulin glargine in patients with type 1 diabetes mellitus: the ELEMENT 1 study
Pollom, R. K.
Blevins, T.
Dahl, D.
Rosenstock, J.
Huster, W. J.
Ilag, L. L.
Prince, M. J.
DIABETOLOGIA, 2014, 57 : S69 - S69
[47] COST-EFFECTIVENESS OF INSULIN DEGLUDEC COMPARED WITH INSULIN GLARGINE FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATING INSULIN THERAPY IN THE UNITED KINGDOM
Evans, M.
Chubb, B.
Christensen, T.
Gundgaard, J.
Wolden, M.
VALUE IN HEALTH, 2013, 16 (07) : A442 - A442
[48] The Risk of Severe Hypoglycemia in Patients with Type 2 Diabetes Mellitus Starting Insulin Therapy with Premixed Insulin Analogues Taken Twice Daily: An Observational Study in Turkish Patients
Gonen, Mustafa Sait
Yurumez, Adem
Hersek, Omer
Altunoglu, Esma
Rakici, Halil
Scism-Bacon, Jamie
Abdulnabi, Radhi
Ertekin, Ali
TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 17 (04) : 83 - 88
[49] Retrospective case-control study comparing twice daily insulin glargine and insulin detemir in veteran patients with type 2 diabetes
Harmon, Timothy
Worrall, Thomas J.
PHARMACOTHERAPY, 2013, 33 (10): : E184 - E184
[50] Mean postprandial and 24-hour glucose are lower with insulin lispro mixture 25/75 compared with insulin glargine in patients with type 2 diabetes mellitus
Malone, JK
Roach, P
DIABETOLOGIA, 2005, 48 : A301 - A302

← 1 2 3 4 5 →